The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment

Anti-angiogenesis therapy, a promising strategy against cancer progression, is limited by drug-resistance, which could be attributed to changes within the tumor microenvironment. Studies have increasingly shown that combining anti-angiogenesis drugs with immunotherapy synergistically inhibits tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Haoyue, Chen, Yue, Tan, Songtao, Wu, Silin, Huang, Yan, Fu, Shengya, Luo, Feng, He, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905241/
https://www.ncbi.nlm.nih.gov/pubmed/35281003
http://dx.doi.org/10.3389/fimmu.2022.802846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905241/
https://www.ncbi.nlm.nih.gov/pubmed/35281003
http://dx.doi.org/10.3389/fimmu.2022.802846

Ejemplares similares